Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Frontiers in Digital Health
|
July 9, 2025
Retention and characteristics associated with remote questionnaire completion in a general population cohort study: the project baseline health study
Megan K Carroll, Safa Faheem, Jean Bouteiller, et al.
JAMA
|
November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease
Jessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.
Journal of the American College of Cardiology
|
March 25, 2017
Potent P2Y<sub>12</sub> Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials
Emily S Lau, Eugene Braunwald, Sabina A Murphy, et al.
European Heart Journal
|
September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials
David D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
Circulation Research
|
February 3, 2022
Research Goes Red: Early Experience With a Participant-Centric Registry
Susan C Gilchrist, Jennifer L Hall, Abha Khandelwal, et al.
The New England Journal of Medicine
|
November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndrome
Jessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
Jessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
American Heart Journal
|
September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
JAMA
|
October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Leveraging Deep Learning of Chest Radiograph Images to Identify Individuals at High Risk for Chronic Obstructive Pulmonary Disease
Saman Doroodgar Jorshery, Jay Chandra, Anika S Walia, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Frontiers in Digital Health
|
July 9, 2025
Retention and characteristics associated with remote questionnaire completion in a general population cohort study: the project baseline health study
Megan K Carroll, Safa Faheem, Jean Bouteiller, et al.
JAMA
|
November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease
Jessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.
Journal of the American College of Cardiology
|
March 25, 2017
Potent P2Y<sub>12</sub> Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials
Emily S Lau, Eugene Braunwald, Sabina A Murphy, et al.
European Heart Journal
|
September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials
David D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
Circulation Research
|
February 3, 2022
Research Goes Red: Early Experience With a Participant-Centric Registry
Susan C Gilchrist, Jennifer L Hall, Abha Khandelwal, et al.
The New England Journal of Medicine
|
November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndrome
Jessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
Jessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
American Heart Journal
|
September 1, 2014
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Paul L Hess, Michael J Mirro, Hans-Christoph Diener, et al.
JAMA
|
October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Leveraging Deep Learning of Chest Radiograph Images to Identify Individuals at High Risk for Chronic Obstructive Pulmonary Disease
Saman Doroodgar Jorshery, Jay Chandra, Anika S Walia, et al.
Page
of 7